Home/Filings/4/0000874716-24-000041
4//SEC Filing

POLEWACZYK JAMES F 4

Accession 0000874716-24-000041

CIK 0000874716other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 5:57 PM ET

Size

22.6 KB

Accession

0000874716-24-000041

Insider Transaction Report

Form 4
Period: 2024-02-14
POLEWACZYK JAMES F
Corporate Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-14+20410,770.235 total
  • Exercise/Conversion

    Common Stock

    2024-02-14+22010,990.235 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-141260 total
    Common Stock (126 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-14161160 total
    Common Stock (161 underlying)
  • Tax Payment

    Common Stock

    2024-02-14$560.56/sh279$156,39610,711.235 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-142160 total
    Common Stock (216 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-14220660 total
    Common Stock (220 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-14+16110,566.235 total
  • Exercise/Conversion

    Common Stock

    2024-02-14+21610,405.235 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-14204408 total
    Common Stock (204 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-14+12610,189.235 total
Footnotes (6)
  • [F1]Includes 13.2470 shares purchased under the Issuer Employee Stock Purchase Plan on December 29, 2023.
  • [F2]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020.
  • [F3]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021.
  • [F4]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
  • [F5]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
  • [F6]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024.

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0001389046

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:57 PM ET
Size
22.6 KB